COATED BARRIER FABRIC FOR A REUSABLE MEDICAL PRODUCT
20220205170 · 2022-06-30
Inventors
Cpc classification
B32B2535/00
PERFORMING OPERATIONS; TRANSPORTING
A61B46/40
HUMAN NECESSITIES
B32B5/26
PERFORMING OPERATIONS; TRANSPORTING
Y10T442/2221
GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
B32B7/05
PERFORMING OPERATIONS; TRANSPORTING
B32B2255/02
PERFORMING OPERATIONS; TRANSPORTING
B32B2307/718
PERFORMING OPERATIONS; TRANSPORTING
B32B5/263
PERFORMING OPERATIONS; TRANSPORTING
International classification
D06N3/12
TEXTILES; PAPER
B32B5/02
PERFORMING OPERATIONS; TRANSPORTING
B32B5/26
PERFORMING OPERATIONS; TRANSPORTING
Abstract
A coated barrier fabric for use in a reusable medical product (e.g., surgical gown, surgical drape, etc.) is provided and has two woven or knitted plies. Each of the two plies are coated on one side with a non-fluorine containing polymer and retain similar comfort and feel of uncoated woven or knitted fabrics. The coated sides of the plies face each other (i.e., inwardly) in the interior of the barrier fabric. Because of the orientation of the plies, the coated sides of the plies can come into direct contact with and move freely against each other within the interior of the barrier fabric. The coating on each of the plies is protected from exterior and environmental factors, including repeated institutional laundering/autoclave cycles, that could abrade and degrade the coating. Thus, the useful life of the reusable medical product including the barrier fabric is extended.
Claims
1. A barrier fabric comprising: a first ply and a second ply each comprising a coated side and a non-coated side, wherein the first ply and the second ply are peripherally joined together to form the barrier fabric, wherein the coated side of the first ply and the coated side of the second ply face each other and define an interior of the barrier fabric, with each coated side able to come into direct contact with one another but remain movable thereagainst and able to form a gap therebetween, and wherein the non-coated side of the first ply and the non-coated side of the second ply face opposing directions and define an exterior of the barrier fabric.
2. The fabric of claim 1, wherein the first ply and the second ply are woven or knitted.
3. The fabric of claim 2, wherein the first ply and the second ply are at least partially woven or knitted from monofilament or multifilament yarn.
4. The fabric of claim 3, wherein the first ply and the second ply are entirely woven or knitted from monofilament or multifilament yarn.
5. The fabric of claim 1, wherein the content of the first and second ply comprise at least 25% polyester or at least 25% polyamide.
6. The fabric of claim 5, wherein the content of the first and second ply comprise approximately 100% polyester or approximately 100% polyamide.
7. The fabric of claim 1, wherein the coated side of the first ply and the coated side of the second ply comprise a coating applied at a rate of from 1 g/m.sup.2 to 75 g/m.sup.2.
8. The fabric of claim 1, wherein the combined coating of the coated side of the first ply and the coated side of the second ply is applied at a rate of no more than 100 g/m.sup.2.
9. The fabric of claim 1, wherein the coated side of the first ply and the coated side of the second ply comprise a coating applied at a rate of approximately 25 g/m.sup.2.
10. The fabric of claim 1, wherein the coated side of the first ply and the coated side of the second ply comprise a non-fluorine containing polymer coating.
11. The fabric of claim 10, wherein the polymer coating is selected from the group of non-fluorine containing polymers consisting of acrylic, polyurethane, thermoplastic polyurethane, silicone, and combinations thereof.
12. The fabric of claim 10, wherein the polymer coating is silicone.
13. The fabric of claim 10, wherein the polymer coating is silicone applied at a rate of from 10 g/m.sup.2 to 50 g/m.sup.2, and wherein the content of the first and second ply comprise at least 25% polyester or at least 25% polyamide.
14. A reusable medical product comprising: a two-ply barrier fabric, the fabric including a first ply and a second ply each comprising a coated side and a non-coated side, wherein the first ply and the second ply are peripherally joined together to form the barrier fabric, wherein the coated side of the first ply and the coated side of the second ply face each other and define an interior of the barrier fabric, with each coated side able to come into direct contact with one another but remain movable thereagainst and able to form a gap therebetween, and wherein the non-coated side of the first ply and the non-coated side of the second ply face opposing directions and define an exterior of the barrier fabric.
15. The reusable medical product of claim 14, wherein the medical product tests for 20 cm or more of hydrostatic resistance within a critical zone of the medical product when tested pursuant to an AATCC 127 standardized test method.
16. The reusable medical product of claim 14, wherein the medical product tests for 1 gram or less of penetration within a critical zone of the medical product when tested pursuant to an AATCC 42 standardized test method.
17. The reusable medical product of claim 14, wherein a hydrostatic resistance and impact penetration performance of the medical product withstands at least 10 institutional laundering/autoclave cycles.
18. The reusable medical product of claim 14, wherein the reusable medical product is a surgical or isolation gown.
19. The reusable medical product of claim 18, wherein a critical zone of the gown is fabricated from the two-ply barrier fabric.
20. The reusable medical product of claim 14, wherein the reusable medical product is a surgical drape.
21. The reusable medical product of claim 14, wherein the content of the first and second ply comprise at least 25% polyester or at least 25% polyamide.
22. The reusable medical product of claim 14, wherein the coated side of the first ply and the coated side of the second ply comprise a coating applied at a rate of from 1 g/m.sup.2 to 75 g/m.sup.2.
23. The reusable medical product of claim 14, wherein the coated side of the first ply and the coated side of the second ply comprise a non-fluorine containing polymer coating.
24. The medical surgical product of claim 23, wherein the polymer coating is silicone applied at a rate of from 10 g/m.sup.2 to 50 g/m.sup.2, and wherein the content of the first and second ply comprise at least 25% polyester or at least 25% polyamide
25. A method for making a two-ply barrier fabric for use in a reusable medical product, the method comprising: applying, via a single pass, a non-fluorine containing polymer coating to a side of each of two separate plies of a woven or knitted fabric, wherein the coating is applied at a rate of from 1 g/m.sup.2 to 75 g/m.sup.2; curing, by a single cure process, the coating on the fabric; and peripherally joining together the coated first ply and second ply to form the barrier fabric, wherein the coated side of the first ply and the coated side of the second ply face each other and define an interior of the barrier fabric, with each coated side able to come into direct contact with one another but remain movable thereagainst and able to form a gap therebetween, wherein the non-coated side of the first ply and the non-coated side of the second ply face opposing directions and define an exterior of the barrier fabric, and wherein the barrier fabric is suitable for use within or as a reusable medical product.
26. The method of claim 25, wherein the reusable medical product is a surgical gown, an isolation gown, or a surgical drape.
27. The method of claim 25, wherein the polymer coating is silicon and applied at a rate of from 10 g/m.sup.2 to 50 g/m.sup.2.
28. The method of claim 25, wherein the content of the first and second ply comprise at least 25% polyester or at least 25% polyamide.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0014] The accompanying drawings, which are incorporated in and constitute a part of this specification, illustrate embodiments of the invention and, together with a Detailed Description of the embodiments given below, serve to explain the principles of the invention.
[0015]
[0016]
[0017]
[0018]
DETAILED DESCRIPTION
[0019] The exemplary embodiments described herein are provided for illustrative purposes and are not limiting. Other exemplary embodiments are possible, and modifications may be made to the exemplary embodiments within the scope of the present disclosure. Therefore, this Detailed Description is not meant to limit the scope of the present disclosure.
[0020]
[0021] Use of descriptive terms hereinbelow such a left, right, top, bottom, front, back, or vertical as the terms pertain to or describe the gown 10 are to be interpreted from the viewpoint of a wearer of the gown 10, when properly donned, unless otherwise noted.
[0022] With specific reference to
[0023] One or more of the terminal cuffs 36, in other embodiments, may be absent altogether, with the long sleeves 28, 30 simply defining an opening that is hemmed at a distal end of each sleeve 28, 30. In another example, the long sleeves 28, 30 may be short sleeves or they may be no sleeves at all, if so desired. In other embodiments, the terminal cuff 36 may be replaced with long sleeves 28, 30 having thumb loops, for example. Moreover, although the central body 26 and the sleeves 28, 30 are shown as one piece in
[0024] Still referring to
[0025] It will be appreciated that alternative embodiments can take forms other than a reusable surgical gown 10. For example, the fabric 12 may be alternatively embodied in other reusable medical products such as a surgical drape, stand or table covers, wrappers, or other protective apparel. In the case of an isolation gown, the AAMI PB70 Standard dictates that the critical zones 11 are the entire gown, including the seams, but excluding the cuffs, hems, and bindings. In the case of a surgical drape, the critical zone 11 can be defined as the area of the drape generally surrounding the fenestration. Regardless of the embodiment, it is to be understood that the critical zones 11 of embodiments (e.g., gowns, drapes, etc.) may be fabricated from a coated, two-ply barrier fabric 12. However, the fabric 12 may be used in other embodiments (besides in the critical zones 11 of gowns and drapes). In this way, the fabric 12 is not limited in use to any specific reusable medical product.
[0026] Referring now to
[0027] Referring now to
[0028] As can be seen in
[0029] The material for the coating 42 can be applied to one side of each of the first and second plies 44, 46 via conventional coating technologies to impart a solid, semi-solid, liquid, or vaporized (e.g., sublimation) chemistry to coat one side of the fabric 12, as is known in the industry. For example, the coating 42 may be applied to the fabric 12 using a knife coat, spray coat, foam coat, or similar methodology. It will be understood that alternative methodologies, as generally known in the art, besides those specifically listed can be used to apply the coating 42 to one side of each of the first and second plies 44, 46 of the fabric 12. Upon application, the material for the coating 42 can interact with the surface of the ply 44, 46 in any number of ways, as would be understood in the industry, to provide the coating 42. For example, the applied coating material can adhere to the surface of the ply 44, 46, and may form a layer thereover, such as by binding to surface fibers (e.g., via covalent and/or non-covalent bonds, etc.) or the coating material can become entrapped within the fibers of the ply 44, 46. Further, a combination of some of all of polymerization, bonding, and physical entrapment can be used to adhere the coating 42 to the plies 44, 46.
[0030] Further, when applying the coating 42, it is desirable to limit the penetration of the coating 42 through the ply 44, 46. It is known in the industry that applying a coating to a side of one ply 44, 46 can result in an undesirable “bleed-through” effect in which the applied coating may penetrate therethrough and appear on the other side of the ply 44, 46. It will be understood that the term ‘coated’ as used herein excludes the bleed-through of the coating 42. It will also be understood that the term ‘non-coated’ is inclusive of the bleed-through of coating 42 material. For example, if a coating 42 is applied to one side of a ply 44, 46, then the side of the ply 44, 46 that the coating 42 was applied to would be considered ‘coated’; however, the opposing side of the ply 44, 46, to which a coating 42 was not applied, could be considered ‘non-coated’, even if it exhibits bleed through effects from the coating 42 on the opposing side of the ply 44, 46.
[0031] Still referring to
[0032] When the coating 42 is applied to a ply (first or second ply 44, 46 of the fabric 12), the coating 42 can be applied at a rate of from 1 grams per square meter (“g/m.sup.2”) to 75 g/m.sup.2. More specifically, in one embodiment, the coating 42 can be applied at a rate of from 10 g/m.sup.2 to 65 g/m.sup.2. In another embodiment, the coating 42 can be applied at a rate of from 15 g/m.sup.2 to 50 g/m.sup.2. In another embodiment, the coating 42 can be applied at a rate of from 15 g/m.sup.2 to 35 g/m.sup.2. In a further embodiment, the coating 42 can be applied at a rate of from 20 g/m.sup.2 to 30 g/m.sup.2. Even more specifically, in an embodiment, the coating 42 can be applied at a rate of approximately 1, 2, 5, 10, 15, 20, or 25 g/m.sup.2. Further, in an embodiment, the total, cumulative weight of the coating 42 across both the first ply 44 and second ply 46, combined, can be 100 g/m.sup.2 or less. In another embodiment, the total, cumulative weight of the coating 42 across both the first ply 44 and second ply 46, combined, can be 75 g/m.sup.2 or less. In yet another embodiment, the total, cumulative weight of the coating 42 across both the first ply 44 and second ply 46, combined, can be 50 g/m.sup.2 or less. For example, the coating 42 on the first and second plies 44, 46 may be 20 g/m.sup.2 each—for a total of 40 g/m.sup.2 across both plies 44, 46, and performed in a single pass. Alternatively, the coating rate on each ply 44, 46 may vary. For example, the coating 42 on the first ply 44 may be 20 g/m.sup.2 and the coating 42 on the second ply 46 may be 25 g/m.sup.2—for a total of 45 g/m.sup.2 across both plies 44, 46, and performed in a single pass.
[0033] Applying such a light coating 42 to the first and second plies 44, 46 of the fabric 12 results in plies 44, 46 with a desirable comfort and feel. Some known coated fabrics used in reusable medical products feature thick coatings. As such, these fabrics have an unpleasant rubber-like feel. Specifically, medical apparel made from such thickly coated fabrics are uncomfortable to wear, especially for long durations of time (such as during a medical procedure). In contrast, applying a light coating 42 on the first and second plies 44, 46 (as opposed to a thicker coating on a single ply) results in a finished fabric 12 that is similar in feel and comfort to an uncoated fabric, but with the desirable barrier properties of a coated fabric 12. As such, the fabric 12 achieves the desirable properties of a reusable barrier fabric without sacrificing on comfort or feel.
[0034] Still referring to
[0035] Referring now specifically to
[0036] Because only the interior-facing sides of the first and second plies 44, 46 are coated, it is understood that the coating 42 of the first ply 44 will rub, but still move freely due to coating characteristics, against the coating 42 of the second ply 46. Such is preferable to the coated side of either ply being directly exposed to the outside or exterior environment. Coatings 42 are generally abraded and/or degraded when they come into contact with any number of environmental factors. For example, if the coated side of the ply were on the exterior 50 of the fabric 12 as opposed to the interior 48, then the coating 42 would be exposed during the institutional laundering/autoclave cycle where the coating 42 could be damaged by the harsh detergents, agitation during a washing phase, or heat during a drying phase. Such abuse could severely diminish the useful life of the fabric 12 as a barrier fabric by degrading the coating 42.
[0037] Still referring to
[0038] Referring now specifically to
[0039] Referring generally to
[0040] Advantageously, the coated, two-ply barrier fabric 12 described herein avoids problems of other barrier fabrics known in the art. For example, the two-ply construction of the fabric 12, where the coated side of the first ply 44 and coated side of the second ply 46 are interior 48 facing, enhances the durability of the fabric 12. By protecting the coating 42 from environmental factors (e.g., institutional laundering/autoclave cycles) the useful life of the fabric 12 is extended. Other known barrier fabrics often utilize chemical hydrophobic finishes, containing fluorocarbons, that are known to diminish through repeated processing and use cycles. Leaving the coating exposed can drastically reduce the lifespan of the barrier fabric. Furthermore, the construction of the fabric 12 offers a more reliable barrier without sacrificing the feel of the fabric 12. By utilizing two plies 44, 46 with thin coatings 42, the fabric 12 can achieve the barrier properties of a fabric with a much thicker coating without compromising on the feel of the fabric. Whereas fabrics known in the art with thicker coatings typically have an uncomfortable, undesirable rubber-like feel, the fabric 12 described above maintains the feel and comfort of a woven or knitted fabric because the coated sides of the plies 44, 46 are not exposed to a user or wearer. Moreover, the two coated plies 44, 46 of the fabric 12 offer a barrier redundancy not offered by coated barrier fabrics known in the art. The two-ply configuration of the fabric 12 yields a higher hydrostatic resistance than either of the two plies 44, 46 would yield individually or would be yielded by a single layer or ply that was coated with the same quantity of coating 42 utilized cumulatively for the two individual plies 44, 46. These, other features, and combinations thereof (as described in the preceding paragraphs) improve upon the shortcomings of reusable barrier fabrics known in the art. Other advantages and technical effects of the embodiments of this invention will become evident to one skilled in the art from the preceding description.
[0041] While the present invention has been illustrated by the description of various embodiments and while these embodiments have been described in some detail, it is not the intention of the Applicant to restrict or in any way limit the scope of the invention to such detail. Additional advantages and modifications will readily appear to those skilled in the art. The invention in its broader aspects is therefore not limited to the specific details and illustrative examples shown and described. Accordingly, departures may be made from such details without departing from the scope of the general inventive concept.